SUGAR LAND, Texas, Feb. 27, 2018 /PRNewswire/ -- Researched by Industrial Info Resources (Sugar Land, Texas)--The European Pharmaceutical & Biotech Industry, better described as the Life Science Industry, includes the development and production of pharmaceuticals, biologicals, medical devices and cosmetics. Europe's volume of project activity continues to impress, all the more so, when the reported activity is expanded to include Russia and Turkey in Western Asia.
For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at www.industrialinfo.com.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.
Brian Ford
(713) 980-9393
View original content with multimedia:http://www.prnewswire.com/news-releases/europe-launches-2018-with-33-billion-investment-in-first-quarter-pharmaceutical-biotech-construction-starts-an-industrial-info-news-alert-300604491.html
SOURCE Industrial Info Resources, Inc.
Share this article